Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Philip E. Dubé"'
Autor:
Emilie Viennois, Alexis Bretin, Philip E. Dubé, Alexander C. Maue, Charlène J.G. Dauriat, Nicolas Barnich, Andrew T. Gewirtz, Benoit Chassaing
Publikováno v:
Cell Reports, Vol 33, Iss 1, Pp 108229- (2020)
Summary: Dietary emulsifiers carboxymethylcellulose (CMC) and polysorbate-80 (P80) disturb gut microbiota, promoting chronic inflammation. Mice with minimal microbiota are protected against emulsifiers’ effects, leading us to hypothesize that these
Externí odkaz:
https://doaj.org/article/294e9d95f9a74e06b8f9a1f09677ed89
Autor:
Cambrian Y. Liu, Sharon S. Tam, Ying Huang, Philip E. Dubé, Rabea Alhosh, Nandini Girish, Shivesh Punit, Shirin Nataneli, Fan Li, Jeffrey M. Bender, M. Kay Washington, D. Brent Polk
Publikováno v:
Cell Reports, Vol 33, Iss 3, Pp 108275- (2020)
Summary: Neutralization of tumor necrosis factor (TNF) represents a widely used therapeutic strategy for autoimmune diseases including inflammatory bowel disease (IBD). However, the fact that many patients with IBD are non-responsive to anti-TNF ther
Externí odkaz:
https://doaj.org/article/0fe74f5d15b644d881e13ea53b0adcd1
Autor:
Cambrian Y. Liu, Nandini Girish, Marie L. Gomez, Philip E. Dubé, M. Kay Washington, Benjamin D. Simons, D. Brent Polk
Publikováno v:
Gastroenterology
BACKGROUND AND AIMS: Epithelial wound healing is compromised and represents an unleveraged therapeutic target in inflammatory bowel disease (IBD). Intestinal epithelial cells exhibit plasticity that facilitates dedifferentiation and repair during the
Autor:
Michael Peel, Brian Long, Lynn Stephens, Eduardo Huarte, Sarala Sarah, Philip E. Dubé, Becky Stewart, Paul A. Smith, P. M. Czerniak, Ashish Juvekar, Julian Oliver
Publikováno v:
Immunotherapy. 13(12)
Aim: Graft-versus-host disease (GvHD) is a major complication arising in patients undergoing allogenic hematopoietic stem cell transplantation. Material & methods: We tested ruxolitinib (a selective JAK1/2 inhibitor) efficacy in three different precl
Autor:
Chengyu Liu, Philip E. Dubé, Nandini Girish, Mary Kay Washington, Benjamin D. Simons, D. Polk, Gomez Ml
SummaryIntestinal epithelial wound healing, which is essential for health, is compromised and represents a therapeutic target in inflammatory bowel disease (IBD). While studies have elucidated important subpopulations of intestinal epithelial cells i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df8bacc0b81da46cafc36fe537120660
https://doi.org/10.1101/2021.06.02.446836
https://doi.org/10.1101/2021.06.02.446836
Autor:
Paul Volden, Suominen Suominen, Jenni H. Mäki-Jouppila, Mari I. Suominen, Justyna Zdrojewska, Philip E. Dubé, Jukka P. Rissanen, Ivan Gladwyn-Ng
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background The recent KEYNOTE-199 trial raises hope for new treatment options for prostate cancer patients with the encouraging results of checkpoint inhibitor activity in a subset of prostate cancer patients, also including patients with bone-predom
Autor:
Benoit Chassaing, Nicolas Barnich, Emilie Viennois, Philip E. Dubé, Alexis Bretin, Alexander C. Maue, Charlène J.G. Dauriat, Andrew T. Gewirtz
Publikováno v:
Cell Reports, Vol 33, Iss 1, Pp 108229-(2020)
Cell Reports
Cell Reports, 2020, 33 (1), pp.108229. ⟨10.1016/j.celrep.2020.108229⟩
Cell Reports, Elsevier Inc, 2020, 33 (1), pp.108229. ⟨10.1016/j.celrep.2020.108229⟩
Cell Reports
Cell Reports, 2020, 33 (1), pp.108229. ⟨10.1016/j.celrep.2020.108229⟩
Cell Reports, Elsevier Inc, 2020, 33 (1), pp.108229. ⟨10.1016/j.celrep.2020.108229⟩
Summary Dietary emulsifiers carboxymethylcellulose (CMC) and polysorbate-80 (P80) disturb gut microbiota, promoting chronic inflammation. Mice with minimal microbiota are protected against emulsifiers’ effects, leading us to hypothesize that these
Autor:
Ying Huang, Jeffrey M. Bender, Philip E. Dubé, Shirin Nataneli, Fan Li, Cambrian Y. Liu, M. Kay Washington, Rabea Alhosh, D. Brent Polk, Shivesh Punit, Nandini Girish, Sharon S. Tam
Publikováno v:
Cell Reports, Vol 33, Iss 3, Pp 108275-(2020)
Cell reports
Cell reports
SUMMARY Neutralization of tumor necrosis factor (TNF) represents a widely used therapeutic strategy for autoimmune diseases including inflammatory bowel disease (IBD). However, the fact that many patients with IBD are non-responsive to anti-TNF thera
Autor:
Julian Oliver, Lynn Stephens, Eduardo Huarte, Brian Long, Michael Peel, Becky Stewart, Philip Czerniak, Philip E. Dubé, Paul Smith
Publikováno v:
Blood. 136:21-22
Background: Graft-versus-host disease (GvHD) is defined as a syndrome in which cells originating from a donor recognize and mount a deleterious immune response against antigens found in the immunocompromised recipient. Most humanized pre-clinical stu
Autor:
Jenni Bernoulli, Jenni Mäki-Jouppila, Mari I. Suominen, Philip E. Dubé, Tiina E. Kähkönen, Michael Seiler, Jussi M. Halleen, Azusa Tanaka
Publikováno v:
Molecular Cancer Therapeutics. 18:B143-B143
Background: Immunotherapy is an emerging treatment option for different subtypes of breast cancer. Pembrolizumab (Keytruda®) targets PD-1 expressing T cells in tumors and mediates anti-tumor effects. Targeting PD-1 has shown promising results in adv